Vernon Taylor
Payments from drug & device makers
Across 327 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$906
- Amgen$641
- AbbVie$575
- AstraZeneca$571
- Novo Nordisk$508
- Bayer$481
- plus $1K from 20 others
What the payments were for
- Food & beverage$5,07398%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 73 | $906 |
| Amgen | 34 | $641 |
| AbbVie | 46 | $575 |
| AstraZeneca(2 entities) | 24 | $571 |
| Novo Nordisk | 34 | $508 |
| Bayer | 31 | $481 |
| Sanofi-aventis U.S. LLC | 13 | $217 |
| Biohaven Pharmaceuticals, Inc. | 11 | $208 |
| Otsuka America Pharmaceutical, Inc. | 8 | $165 |
| Astellas Pharma US Inc | 5 | $153 |
| Amarin Pharma, Inc. | 8 | $113 |
| Merck | 5 | $94 |
| Pfizer | 5 | $79 |
| GSK | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 4 | $65 |
| Novartis | 4 | $56 |
| Abbott | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $51 |
| Johnson & Johnson | 3 | $45 |
| Indivior Inc. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
- NURTEC ODT$102
How this compares
$5,167 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 111 | $145,484 |
| OzempicSemaglutide | 67 | $91,698 |
| TrulicityDulaglutide | 44 | $54,844 |
| FarxigaDapagliflozin Propanediol | 43 | $40,819 |
| EliquisApixaban | 36 | $36,221 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 42 | $36,136 |
| JardianceEmpagliflozin | 28 | $35,377 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $25,198 |
| Repatha SureclickEvolocumab | 35 | $22,622 |
| RexultiBrexpiprazole | 13 | $21,375 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $19,793 |
| LinzessLinaclotide | 27 | $19,380 |
| VascepaIcosapent Ethyl | 19 | $14,286 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $12,567 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $9,985 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $906 | $200,328155 claims |
| Novo NordiskOzempic | $508 | $91,69867 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $571 | $76,95585 claims |
| PfizerEliquis | $79 | $36,22136 claims |
| Boehringer IngelheimJardiance | $11 | $35,37728 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $69 | $35,18353 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $165 | $21,37513 claims |
| AbbVieLinzess, Synthroid | $575 | $20,73849 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Gray
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.